NEPHROS INC (NEPH)
US6406714005 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.46M | 4.31M | 3.63M | 6.97M | 8.25M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | N/A | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 1.69M | 1.50M | 1.29M | 1.64M | 1.36M | |||
| Inventories | 3.10M | 2.47M | 3.15M | 4.80M | 5.30M | |||
| Other Current Assets | 109.00K | 132.00K | 190.00K | 230.00K | 240.00K | |||
| Total Current Assets | 7.36M | 8.40M | 8.26M | 13.63M | 15.15M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.63M | 1.96M | 1.10M | 1.10M | 1.33M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 759.00K | 759.00K | 760.00K | 760.00K | 760.00K | |||
| Intangibles | 587.00K | 652.00K | 830.00K | 2.07M | 1.18M | |||
| Other Non-Current Assets | 50.00K | 86.00K | 50.00K | 90.00K | 90.00K | |||
| Total Non-Current Assets | 3.03M | 3.46M | 2.74M | 4.02M | 3.36M | |||
| TOTAL ASSETS | 10.39M | 11.86M | 11.00M | 17.65M | 18.51M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 5.00K | 4.00K | 80.00K | 260.00K | 240.00K | |||
| Accrued Expenses | 655.00K | 1.24M | 590.00K | 800.00K | 660.00K | |||
| Accounts Payable | 398.00K | 873.00K | 740.00K | 1.33M | 420.00K | |||
| Other Current Liabilities | N/A | N/A | 0.00 | N/A | 0.00 | |||
| Total Current Liabilities | 1.06M | 2.11M | 1.41M | 2.39M | 1.33M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 18.00K | 0.00 | 10.00K | 110.00K | 880.00K | |||
| Other Non-Current Liabilities | 1.14M | 1.39M | 700.00K | 400.00K | 740.00K | |||
| Total Non-Current Liabilities | 1.15M | 1.39M | 4.00M | 3.57M | 4.66M | |||
| TOTAL LIABILITIES | 2.21M | 3.50M | 5.41M | 5.96M | 5.99M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -144.68M | -144.41M | -142.83M | -135.73M | -131.86M | |||
| Additional Paid In Capital | 152.84M | 152.75M | 148.41M | 147.35M | 144.30M | |||
| Minority Interest | N/A | 0.00 | 3.29M | 3.05M | 3.05M | |||
| Common Shares | 11.00K | 10.00K | 10.00K | 10.00K | 10.00K | |||
| Other Shareholders' Equity | N/A | 0.00 | 0.00 | 60.00K | 70.00K | |||
| Shares Outstanding | 10.54M | 10.54M | 10.30M | 10.26M | 9.87M | |||
| Tangible Book Value per Share | 0.65 | 0.66 | 0.39 | 0.86 | 1.07 | |||
| Total Shareholders' Equity | 8.17M | 8.36M | 5.59M | 11.70M | 12.52M | |||
| TOTAL LIABILITIES AND EQUITY | 10.39M | 11.86M | 11.00M | 17.65M | 18.51M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | N/A | 0.00 | 0.01 | 0.07 | |||
| Current Ratio | 6.95 | 3.98 | 5.86 | 5.70 | 11.39 | |||
| Return On Assets (ROA) | -8.94% | -13.28% | -67.09% | -23.29% | -25.77% | |||
| Return On Equity (ROE) | -11.37% | -18.84% | -132.02% | -35.13% | -38.10% | |||
All data in USD , ROIC based on taxRate of 0.21